Spike protein of SARS-CoV-2 variants: a brief review and practical implications

被引:18
作者
Candido, Kattlyn Laryssa [1 ]
Eich, Caio Ricardo [1 ]
de Farina, Luciana Oliveira [1 ]
Kadowaki, Marina Kimiko [1 ]
da Conceicao Silva, Jose Luis [1 ]
Maller, Alexandre [1 ]
Garcia Simao, Rita de Cassia [1 ]
机构
[1] Univ Estadual Oeste Parana, Lab Bioquim Mol LaBioqMol, Ctr Ciencias Med & Farmaceut, Cascavel, PR, Brazil
关键词
Brazil; COVID-19; Public health; SARS-CoV-2; Variants; Viral diseases; UNITED-STATES; HEPATITIS-A; VACCINE; COVID-19; CORONAVIRUS; MUTATIONS; ESCAPE; INFECTION; AFFINITY; VIRUS;
D O I
10.1007/s42770-022-00743-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The scientific community has been alarmed by the possible immunological evasion, higher infectivity, and severity of disease caused by the newest variants of SARS-CoV-2. The spike protein has an important role in the cellular invasion of viruses and is the target of several vaccines and therapeutic resources, such as monoclonal antibodies. In addition, some of the most relevant mutations in the different variants are on the spike (S) protein gene sequence that leads to structural alterations in the predicted protein, thus causing concern about the protection mediated by vaccines against these new strains. The present review highlights the most recent knowledge about COVID-19 and vaccines, emphasizing the different spike protein structures of SARS-CoV-2 and updating the reader about the emerging viral variants and their classifications, the more common viral mutations described and their distribution in Brazil. It also compiles a table with the most recent knowledge about all of the Omicron spike mutations.
引用
收藏
页码:1133 / 1157
页数:25
相关论文
共 233 条
  • [1] SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
    Abdelghany, T. M.
    Ganash, Magdah
    Bakri, Marwah M.
    Qanash, Husam
    Al-Rajhi, Aisha M. H.
    Elhussieny, Nadeem, I
    [J]. BIOMEDICAL JOURNAL, 2021, 44 (01) : 86 - 93
  • [2] Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    Yassine, Hadi M.
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    Tang, Patrick
    Hasan, Mohammad R.
    Coyle, Peter
    AlMukdad, Sawsan
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al Kuwari, Mohamed Ghaith
    Butt, Adeel A.
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E1188 - E1191
  • [3] Prediction of Residue-specific Contributions to Binding and Thermal Stability Using Yeast Surface Display
    Ahmed, Shahbaz
    Bhasin, Munmun
    Manjunath, Kavyashree
    Varadarajan, Raghavan
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [4] Bioinformatics Analysis Unveils Certain Mutations Implicated in Spike Structure Damage and Ligand-Binding Site of Severe Acute Respiratory Syndrome Coronavirus 2
    Aktas, Emre
    [J]. BIOINFORMATICS AND BIOLOGY INSIGHTS, 2021, 15
  • [5] Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency
    Alaofi, Ahmed L.
    Shahid, Mudassar
    [J]. BIOMOLECULES, 2021, 11 (09)
  • [6] Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study
    Allen, Hester
    Vusirikala, Amoolya
    Flannagan, Joe
    Twohig, Katherine A.
    Zaidi, Asad
    Chudasama, Dimple
    Lamagni, Theresa
    Groves, Natalie
    Turner, Charlie
    Rawlinson, Christopher
    Lopez-Bernal, Jamie
    Harris, Ross
    Charlett, Andre
    Dabrera, Gavin
    Kall, Meaghan
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2022, 12
  • [7] [Anonymous], 2021, LANCET, V397, P941, DOI 10.1016/S0140-6736(21)00617-6
  • [8] [Anonymous], AD26 COV2 S VACC PRE
  • [9] [Anonymous], 2021, WHO TRACKING SARS CO
  • [10] [Anonymous], 2021, WHO Coronavirus